Literature DB >> 26584444

Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens.

Sandra March1,2, Vyas Ramanan2, Kartik Trehan2, Shengyong Ng2,3, Ani Galstian1,2, Nil Gural2, Margaret A Scull4, Amir Shlomai4, Maria M Mota5, Heather E Fleming2, Salman R Khetani6, Charles M Rice4, Sangeeta N Bhatia1,2,7,8,9,10.   

Abstract

The development of therapies and vaccines for human hepatropic pathogens requires robust model systems that enable the study of host-pathogen interactions. However, in vitro liver models of infection typically use either hepatoma cell lines that exhibit aberrant physiology or primary human hepatocytes in culture conditions in which they rapidly lose their hepatic phenotype. To achieve stable and robust in vitro primary human hepatocyte models, we developed micropatterned cocultures (MPCCs), which consist of primary human hepatocytes organized into 2D islands that are surrounded by supportive fibroblast cells. By using this system, which can be established over a period of days, and maintained over multiple weeks, we demonstrate how to recapitulate in vitro hepatic life cycles for the hepatitis B and C viruses and the Plasmodium pathogens P. falciparum and P. vivax. The MPCC platform can be used to uncover aspects of host-pathogen interactions, and it has the potential to be used for drug and vaccine development.

Entities:  

Mesh:

Year:  2015        PMID: 26584444      PMCID: PMC5867906          DOI: 10.1038/nprot.2015.128

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  84 in total

Review 1.  Evolving concepts in liver tissue modeling and implications for in vitro toxicology.

Authors:  André Guillouzo; Christiane Guguen-Guillouzo
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-10       Impact factor: 4.481

2.  Malaria sporozoite penetration. A new approach by double staining.

Authors:  L Rénia; F Miltgen; Y Charoenvit; T Ponnudurai; J P Verhave; W E Collins; D Mazier
Journal:  J Immunol Methods       Date:  1988-09-13       Impact factor: 2.303

3.  In vitro culture of exoerythrocytic parasites of the North Korean strain of Plasmodium vivax in hepatoma cells.

Authors:  M R Hollingdale; W E Collins; C C Campbell
Journal:  Am J Trop Med Hyg       Date:  1986-03       Impact factor: 2.345

4.  Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures.

Authors:  Laurent Dembélé; Jean-François Franetich; Audrey Lorthiois; Audrey Gego; Anne-Marie Zeeman; Clemens H M Kocken; Roger Le Grand; Nathalie Dereuddre-Bosquet; Geert-Jan van Gemert; Robert Sauerwein; Jean-Christophe Vaillant; Laurent Hannoun; Matthew J Fuchter; Thierry T Diagana; Nicholas A Malmquist; Artur Scherf; Georges Snounou; Dominique Mazier
Journal:  Nat Med       Date:  2014-02-09       Impact factor: 53.440

5.  Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.

Authors:  J E Epstein; K Tewari; K E Lyke; B K L Sim; P F Billingsley; M B Laurens; A Gunasekera; S Chakravarty; E R James; M Sedegah; A Richman; S Velmurugan; S Reyes; M Li; K Tucker; A Ahumada; A J Ruben; T Li; R Stafford; A G Eappen; C Tamminga; J W Bennett; C F Ockenhouse; J R Murphy; J Komisar; N Thomas; M Loyevsky; A Birkett; C V Plowe; C Loucq; R Edelman; T L Richie; R A Seder; S L Hoffman
Journal:  Science       Date:  2011-09-08       Impact factor: 47.728

Review 6.  Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.

Authors:  Timothy N C Wells; Jeremy N Burrows; J Kevin Baird
Journal:  Trends Parasitol       Date:  2010-02-03

7.  Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties.

Authors:  Stefan Wilkening; Frank Stahl; Augustinus Bader
Journal:  Drug Metab Dispos       Date:  2003-08       Impact factor: 3.922

Review 8.  New medicines to improve control and contribute to the eradication of malaria.

Authors:  Timothy N C Wells; Pedro L Alonso; Winston E Gutteridge
Journal:  Nat Rev Drug Discov       Date:  2009-10-16       Impact factor: 84.694

9.  Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus.

Authors:  Dieter Glebe; Mehriar Aliakbari; Peter Krass; Eva V Knoop; Klaus P Valerius; Wolfram H Gerlich
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

View more
  54 in total

Review 1.  Physiologically relevant human tissue models for infectious diseases.

Authors:  Melody Mills; Mary K Estes
Journal:  Drug Discov Today       Date:  2016-06-25       Impact factor: 7.851

2.  Steroid Hormone Function Controls Non-competitive Plasmodium Development in Anopheles.

Authors:  Kristine Werling; W Robert Shaw; Maurice A Itoe; Kathleen A Westervelt; Perrine Marcenac; Douglas G Paton; Duo Peng; Naresh Singh; Andrea L Smidler; Adam South; Amy A Deik; Liliana Mancio-Silva; Allison R Demas; Sandra March; Eric Calvo; Sangeeta N Bhatia; Clary B Clish; Flaminia Catteruccia
Journal:  Cell       Date:  2019-03-28       Impact factor: 41.582

3.  Targeting liver stage malaria with metformin.

Authors:  Iset Medina Vera; Margarida T Grilo Ruivo; Leonardo F Lemos Rocha; Sofia Marques; Sangeeta N Bhatia; Maria M Mota; Liliana Mancio-Silva
Journal:  JCI Insight       Date:  2019-12-19

4.  One step fabrication of hydrogel microcapsules with hollow core for assembly and cultivation of hepatocyte spheroids.

Authors:  Christian Siltanen; Michalitsa Diakatou; Jeremy Lowen; Amranul Haque; Ali Rahimian; Gulnaz Stybayeva; Alexander Revzin
Journal:  Acta Biomater       Date:  2017-01-06       Impact factor: 8.947

Review 5.  Cell sources for in vitro human liver cell culture models.

Authors:  Katrin Zeilinger; Nora Freyer; Georg Damm; Daniel Seehofer; Fanny Knöspel
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-05

Review 6.  Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.

Authors:  Ying I Wang; Carlos Carmona; James J Hickman; Michael L Shuler
Journal:  Adv Healthc Mater       Date:  2017-12-04       Impact factor: 9.933

Review 7.  Hepatitis E virus: advances and challenges.

Authors:  Ila Nimgaonkar; Qiang Ding; Robert E Schwartz; Alexander Ploss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-22       Impact factor: 46.802

Review 8.  Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis.

Authors:  Abdul M Oseini; Banumathi K Cole; Danny Issa; Ryan E Feaver; Arun J Sanyal
Journal:  Hepatol Int       Date:  2018-01-03       Impact factor: 6.047

9.  Long-Term Engineered Cultures of Primary Mouse Hepatocytes for Strain and Species Comparison Studies During Drug Development.

Authors:  Brenton R Ware; Grace E Brown; Valerie Y Soldatow; Edward L LeCluyse; Salman R Khetani
Journal:  Gene Expr       Date:  2019-07-24

10.  Diversity-oriented synthesis yields novel multistage antimalarial inhibitors.

Authors:  Nobutaka Kato; Eamon Comer; Tomoyo Sakata-Kato; Arvind Sharma; Manmohan Sharma; Micah Maetani; Jessica Bastien; Nicolas M Brancucci; Joshua A Bittker; Victoria Corey; David Clarke; Emily R Derbyshire; Gillian L Dornan; Sandra Duffy; Sean Eckley; Maurice A Itoe; Karin M J Koolen; Timothy A Lewis; Ping S Lui; Amanda K Lukens; Emily Lund; Sandra March; Elamaran Meibalan; Bennett C Meier; Jacob A McPhail; Branko Mitasev; Eli L Moss; Morgane Sayes; Yvonne Van Gessel; Mathias J Wawer; Takashi Yoshinaga; Anne-Marie Zeeman; Vicky M Avery; Sangeeta N Bhatia; John E Burke; Flaminia Catteruccia; Jon C Clardy; Paul A Clemons; Koen J Dechering; Jeremy R Duvall; Michael A Foley; Fabian Gusovsky; Clemens H M Kocken; Matthias Marti; Marshall L Morningstar; Benito Munoz; Daniel E Neafsey; Amit Sharma; Elizabeth A Winzeler; Dyann F Wirth; Christina A Scherer; Stuart L Schreiber
Journal:  Nature       Date:  2016-09-07       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.